CorMedix Ownership | Who Owns CorMedix?


OverviewForecastRevenueFinancialsChartTranscripts

CorMedix Ownership Summary


CorMedix is owned by 38.43% institutional investors, 1.44% insiders, and 60.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.77% of CRMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.07% of its assets in CorMedix shares.

CRMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorMedix38.43%1.44%60.12%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.57M7.77%$37.00M
Blackrock3.55M6.18%$15.39M
Vanguard group3.38M5.74%$27.36M
Elliott investment management2.87M4.88%$23.25M
Nomura1.42M2.47%$6.16M
State street1.45M2.47%$11.77M
Geode capital management1.39M2.37%$11.28M
First turn management1.02M1.74%$8.27M
J. goldman & co lp457.32K0.78%$3.70M
Northern trust445.68K0.78%$1.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Spinnaker capital175.38K100.00%$1.42M
First turn management1.02M1.48%$8.27M
Planning directions50.00K0.23%$405.00K
Elliott investment management2.87M0.14%$23.25M
J. goldman & co lp457.32K0.10%$3.70M
Palumbo wealth management30.33K0.09%$245.64K
Oxford asset management llp21.45K0.09%$173.75K
Kennedy capital management378.24K0.07%$3.06M
Gsg advisors26.50K0.07%$214.65K
Nicholas investment partners, lp94.13K0.07%$762.47K

Top Buyers

HolderShares% AssetsChange
Elliott investment management2.87M0.14%1.32M
First turn management1.02M1.48%1.02M
Blackrock funding, inc. /de4.57M0.00%911.60K
Ubs group379.87K0.00%340.35K
J. goldman & co lp457.32K0.10%314.88K

Top Sellers

HolderShares% AssetsChange
Nomura1.42M0.01%-1.53M
Rosalind advisors---1.48M
Voya investment management17.66K0.00%-721.40K
Susquehanna group, llp26.73K--195.90K
Marshall wace, llp---161.75K

New Positions

HolderShares% AssetsChangeValue
First turn management1.02M1.48%1.02M$8.27M
Raymond james financial115.66K0.00%115.66K$936.85K
Nicholas investment partners, lp94.13K0.07%94.13K$762.47K
Cubist systematic strategies72.35K0.00%72.35K$586.07K
Advisory services network51.60K0.01%51.60K$417.96K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Nelson, van denburg & campbell wealth management group-11.00
Srs capital advisors-31.00
Capital performance advisors llp-47.00
Nvwm-125.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202413424.07%22,609,36218.08%383.63%8953.45%21-
Sep 30, 20241073.88%19,101,28511.30%323.65%587.41%20-9.09%
Jun 30, 20241038.42%17,161,283-0.70%293.20%5474.19%22-35.29%
Mar 31, 202495-9.52%17,281,794-7.60%302.79%31-42.59%3478.95%
Dec 31, 202310510.53%18,704,2184.63%332.13%545.88%19-5.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.98M3.07%-
Vanguard US Total Market Shares ETF1.73M2.66%-
iShares Russell 2000 ETF1.61M2.46%-13.91K
Fidelity Small Cap Growth1.16M1.77%1.16M
Vanguard Institutional Extnd Mkt Idx Tr946.76K1.47%-8.39K
Fidelity Small Cap Index597.79K0.92%-11.20K
Fidelity Small Cap Growth K6533.26K0.82%533.26K
iShares Russell 2000 Growth ETF486.67K0.75%-2.32K
Voya Small Cap Growth (Portland)409.32K0.67%409.32K
Voya Small Cap Growth I391.30K0.64%-18.02K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 31, 2024Mistry Erin EVP, Chief Commercial OfficerBuy$14.98K
Nov 14, 2024Hurlburt Elizabeth EVPSell$1.57M
Mar 13, 2024Todisco Joseph Chief Executive OfficerBuy$50.72K
Dec 14, 2023DUNTON ALAN W-Buy$10.35K
Dec 15, 2023DUNTON ALAN W-Buy$9.90K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q411
2024 Q2--
2024 Q11-

CRMD Ownership FAQ


Who Owns CorMedix?

CorMedix shareholders are primarily institutional investors at 38.43%, followed by 1.44% insiders and 60.13% retail investors. The average institutional ownership in CorMedix's industry, Biotech Stocks , is 68.48%, which CorMedix falls below.

Who owns the most shares of CorMedix?

CorMedix’s largest shareholders are Blackrock funding, inc. /de (4.57M shares, 7.77%), Blackrock (3.55M shares, 6.18%), and Vanguard group (3.38M shares, 5.74%). Together, they hold 19.69% of CorMedix’s total shares outstanding.

Does Blackrock own CorMedix?

Yes, BlackRock owns 6.18% of CorMedix, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.39M$. In the last quarter, BlackRock increased its holdings by 66.48K shares, a 1.91% change.

Who is CorMedix’s biggest shareholder by percentage of total assets invested?

Spinnaker capital is CorMedix’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 175.38K CorMedix shares, valued at 1.42M$.

Who is the top mutual fund holder of CorMedix shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of CorMedix shares, with 3.07% of its total shares outstanding invested in 1.98M CorMedix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools